Not so new drugs for prostate and breast cancer

[Guest guest]

" Researchers from the Netherlands have reported that low-dose radiation from

annual mammograms may increase the risk of breast cancer among women with

genetic or familial predisposition to the disease. These results were presented

at the 2009 meeting of the Radiological Society of North America (RSNA),

November 30-December 4Mammograms are commonly used to screen women for breast

cancer. The age at which screening should begin varies by a woman’s risk of

breast cancer; women at high risk of breast cancer are usually advised to begin

screening at a younger age than average-risk women. "

November 29, 2009

http://www.caring4cancer.com/go/cancer/news?NewsItemId=44345

_______________________________________________

Sprycel may be new drug for prostate cancer. Demember 1, 1009

" Researchers from Italy have reported that Sprycel® (dasatinib) may have

significant activity for treating patients with castration-resistant prostate

cancer (CRPC) with bone metastases. The details of this Phase II study were

published in the December 1, 2009 issue of Clinical Cancer Research. Taxotere

is the single most effective agent for the palliative treatment of CRPC.

However, most patients ultimately fail to respond. Recently, researchers from

Italy have reported that Avastin® (bevacizumab) plus docetaxel (Taxotere®) may

have activity in patients with CRPC who had previously been treated with

Taxotere. "

http://www.caring4cancer.com/go/cancer/news?NewsItemId=44347

Please read all of the information at the websites provided, quotations are only

a small portion.

FYI,

Lottie Duthu